The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells

1. De Vries, J.F.
2. Zwaan, C.M.
3. De Bie, M.
4. Voerman, J.S.A.
5. Den Boer, M.L.
6. Van Dongen, J.J.M.
7. Van Der Velden, V.H.J.